Email updates

Keep up to date with the latest news and content from BMC Molecular Biology and BioMed Central.

Open Access Highly Accessed Research article

EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells

Haijuan Wang1, Katarina Gambosova2, Zachary A Cooper1, Michael P Holloway1, Andrea Kassai1, Denisse Izquierdo1, Kelly Cleveland2, Charlotte M Boney2 and Rachel A Altura1*

Author Affiliations

1 Department of Pediatrics, Division of Pediatric Hematology-Oncology, Brown University, Providence, RI, 02903 USA

2 Department of Pediatrics, Division of Pediatric Endocrinology, Brown University, Providence, RI, 02903 USA

For all author emails, please log on.

BMC Molecular Biology 2010, 11:66  doi:10.1186/1471-2199-11-66

Published: 31 August 2010

Abstract

Background

Postnatal expansion of the pancreatic β-cell mass is required to maintain glucose homeostasis immediately after birth. This β-cell expansion is regulated by multiple growth factors, including glucose, insulin, insulin-like growth factor (IGF-1) and epidermal growth factor (EGF). These mitogens signal through several downstream pathways (AKT, ERK, STAT3, and JNK) to regulate the survival and proliferation of β-cells. Survivin, an oncofetal protein with both pro-proliferative and anti-apoptotic properties, is a known transcriptional target of both IGF-1 and EGF in cancer cells. Here, we analyzed the effects of the β-cell mitogens IGF-1 and EGF on survivin regulation in the established pancreatic β-cell model cell lines, MIN6 and INS-1 and in primary mouse islets.

Results

In pancreatic β-cells, treatment with glucose, insulin, or EGF increased survivin protein levels at early time points. By contrast, no significant effects on survivin were observed following IGF-1 treatment. EGF-stimulated increases in survivin protein were abrogated in the presence of downstream inhibitors of the Raf-1/MEK/ERK pathway. EGF had no significant effect on survivin transcription however it prolonged the half-life of the survivin protein and stabilized survivin protein levels by inhibiting surviving ubiquitination.

Conclusions

This study defines a novel mechanism of survivin regulation by EGF through the Raf-1/MEK/ERK pathway in pancreatic β-cells, via prolongation of survivin protein half-life and inhibition of the ubiquitin-mediated proteasomal degradation pathway. This mechanism may be important for regulating β-cell expansion after birth.